We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
- Authors
Durbin, Anna P; Karron, Ruth A
- Abstract
Respiratory syncytial virus (RSV) and human parainfluenza viruses (hPIVs) are leading causes of viral lower respiratory tract illness in children and in high-risk adult populations. Despite decades of research, licensed vaccines for RSV and hPIVs do not exist. Recently, however, genetically engineered live attenuated RSV and hPIV candidate vaccines have been generated, several of which are already being evaluated in clinical trials. Recombinant technology allows candidate vaccines to be "fine-tuned" in response to clinical data, which should hasten the development of vaccines against these important respiratory pathogens.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Vol 37, Issue 12, p1668
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/379775